Abstract
Community-acquired pneumonia (CAP) is not a homogeneous entity. S. pneumoniae is the most prevalent pathogen associated with severe CAP and is responsible for two-thirds of CAP-related deaths. Today, there is a need for effective strategies to develop and establish the optimum dosage regimen of new antimicrobial options. Morbidity and mortality in cases with severe CAP are determined by a complex interaction between host factors, features of the microorganism and the therapy administered. The major challenge that CAP presents is the early recognition of subsets requiring Intensive Care Unit (ICU) admission. Despite recent advances in antibiotic therapy, severe CAP remains associated with unacceptable levels of mortality. The present manuscript summarizes the current key points that should be taken into account in the strategies for severe CAP management.
Keywords: Community-acquired pneumonia, CAP, sepsis, ICU management, outcome, homogeneous, antimicrobial, host factors, mortality, ANTIBIOTIC USAGE
Current Respiratory Medicine Reviews
Title: Current Key Points in Management for Severe Community-Acquired Pneumonia
Volume: 7 Issue: 4
Author(s): Ignacio Martin-Loeches, Thiago Lisboa and Jordi Rello
Affiliation:
Keywords: Community-acquired pneumonia, CAP, sepsis, ICU management, outcome, homogeneous, antimicrobial, host factors, mortality, ANTIBIOTIC USAGE
Abstract: Community-acquired pneumonia (CAP) is not a homogeneous entity. S. pneumoniae is the most prevalent pathogen associated with severe CAP and is responsible for two-thirds of CAP-related deaths. Today, there is a need for effective strategies to develop and establish the optimum dosage regimen of new antimicrobial options. Morbidity and mortality in cases with severe CAP are determined by a complex interaction between host factors, features of the microorganism and the therapy administered. The major challenge that CAP presents is the early recognition of subsets requiring Intensive Care Unit (ICU) admission. Despite recent advances in antibiotic therapy, severe CAP remains associated with unacceptable levels of mortality. The present manuscript summarizes the current key points that should be taken into account in the strategies for severe CAP management.
Export Options
About this article
Cite this article as:
Martin-Loeches Ignacio, Lisboa Thiago and Rello Jordi, Current Key Points in Management for Severe Community-Acquired Pneumonia, Current Respiratory Medicine Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339811798281214
DOI https://dx.doi.org/10.2174/157339811798281214 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelet Aggregation and Exogenous Factors From Animal Sources
Current Drug Targets - Cardiovascular & Hematological Disorders Pulmonary Hypertension in the Critically Ill
Current Hypertension Reviews Recent Advances in Sepsis Research: Novel Biomarkers and Therapeutic Targets
Current Medicinal Chemistry Insulin and Endothelial Function: Physiological Environment Defines Effect on Atherosclerotic Risk
Current Diabetes Reviews Current Research on Opioid Receptor Function
Current Drug Targets Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials
Current Vascular Pharmacology Obstetrical Hemorrhage Review
Current Women`s Health Reviews Regulation of Sulfotransferases by Xenobiotic Receptors
Current Drug Metabolism Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews Isolation and Purification of Kudinosides from Kuding Tea by Semi-Preparative HPLC Combined with MCI-GEL Resin
Current Analytical Chemistry Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application
Current Protein & Peptide Science Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy
Current Alzheimer Research Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure
Current Vascular Pharmacology Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety
Current Medicinal Chemistry Glucose and LDL Lowering: The Need for Intensive Therapy
Current Vascular Pharmacology Advances in Therapy for Psoriasis: An Overview of Infliximab, Etanercept, Efalizumab, Alefacept, Adalimumab, Tazarotene, and Pimecrolimus
Current Pharmaceutical Design Extraction, Processing, and Stabilization of Health-Promoting Fish Oils
Recent Patents on Food, Nutrition & Agriculture Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Hypertension in Children with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Current Hypertension Reviews A New Phospholipase A<sub>2</sub> from Lachesis <i>muta rhombeata</i>: Purification, Biochemical and Comparative Characterization with Crotoxin B
Protein & Peptide Letters